Cardiff Oncology, Inc.
CRDF· Nasdaq
CRDFCardiff Oncology, Inc.
Filed Apr 1, 2013 · 10-K · 91 days after period end · 0001104659-13-026211
| Metric | Q4 2012 | Q4 2011dderived from reported figures |
|---|---|---|
| Revenue | $163.00K | $33.75K |
| Net Income | -$6.33M | -$1.25M |
| EPS Diluted | -$0.43 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cardiff Oncology, Inc. · CIK 1213037 · Engraved from SEC EDGAR
ended Dec 31, 2012 · filed Apr 1, 2013 · 91 d after period end
